mardi 7 juillet 2020

Human Biobanking Ownership – Global Trends, Estimates and Forecasts, 2014-2020 – Research and Markets

Par Rédaction , dans Communiqués , le 19 mai 2016

Thursday, May 19th 2016 at 2:09pm UTC

DUBLIN–(BUSINESS WIRE)– Research and Markets has announced the addition of the « Human
Biobanking Ownership – Global Trends, Estimates and Forecasts, 2014-2020 »

report to their offering.

The report Human Biobanking Ownership – Global Trends, Estimates and
Forecasts, 2014-2020 reviews the latest human biobanking market trends
with a perceptive attempt to disclose the near-future growth prospects.
An in-depth analysis on a geographic basis provides strategic business
intelligence for life science sector investments. The study reveals
profitable investment strategies for pharmaceutical manufacturers,
biotechnology companies, laboratories, Contract Research Organizations
(CROs) and many more in preferred locations.

Primarily supported by ownership types; Private Biobanks and Public
Biobanks (Disease-Based Banks, Population-Based Banks and Academics)
market is to witness a value of US$37.1 billion by 2020. Geographical
analysis for Private Biobanks shows the highest Compounded Annual Growth
Rate (CAGR) of 10.75% is foreseen from Asia-Pacific region during the
analysis period 2014-2020. North America is not way behind with a CAGR
of 9.95% followed by Europe at 9.56% respectively.

Further, the subdivided categories include:

1. Private Banks

– a. Disease-Based Banks

– b. Population-Based Banks

– c. Academics

2. Public Banks

– a. Disease-Based Banks

– b. Population-Based Banks

– c. Academics

3. Hospitals, Biotechnology & Pharmaceutical Companies, Diagnostics,
Transplantation and Biobank Storage Companies

4. Medical Institutions, Research and Forensics

More than 1270 leading market players are identified and 107 key
companies that project improved market activities in the near future are
profiled. The report consists of 138 data charts describing the market
shares, sales forecasts and growth prospects. Moreover, key strategic
activities in the market including mergers/acquisitions,
collaborations/partnerships, product launches/developments are discussed.

Companies Mentioned – Partial List of the 100+ Companies

– Abbott Laboratories

– Acorda Therapeutics, Inc.

– Affymetrix, Inc.

– Alpha Cord, Inc.

– Aqix

– Atgc Labs

– Autogen, Inc.

– B & C Group

– Babycell Egypt

– Barber Nichols

– Bbmri

– Beckman Coulter, Inc.

– Biobank Ireland Trust

– Biocision

– Biokryo Gmbh

– Biolife Solutions, Inc.

– Biological Specimen Inventory System

– Biomatrica, Inc.

– Biorep Srl P.Iva

– Biostorage Technologies, Inc.

– Biostorage, Llc.

– Boehringer Ingelheim, Gmbh

– Caladrius Biosciences, Inc.

– Cellerant Therapeutics, Inc.

– Cells4Life, Ltd.

– Cesca Therapeutics, Inc.

– Chart Industries, Inc.

– Charter Medical, Ltd.

– China Cord Blood Corporation

– Cole Parmer Instrument, Co.

– Corcell, Inc.

– Cord Blood Registry

– Cordlife Pte., Ltd.

– Core Dynamics (Usa), Inc.

– Cryo Bio System

For more information visit


Research and Markets
Laura Wood, Senior Manager
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
For GMT Office Hours Call +353-1-416-8900
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biotechnology

Source: Research and Markets

Étiquettes : ,